35382471|t|Concurrent suppression of Abeta aggregation and NLRP3 inflammasome activation for treating Alzheimer's disease.
35382471|a|Alzheimer's disease (AD) is a neurodegenerative illness accompanied by severe memory loss, cognitive disorders and impaired behavioral ability. Amyloid beta-peptide (Abeta) aggregation and nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome play crucial roles in the pathogenesis of AD. Abeta plaques not only induce oxidative stress and impair neurons, but also activate the NLRP3 inflammasome, which releases inflammatory cytokine IL-1beta to trigger neuroinflammation. A bifunctional molecule, 2-[2-(benzo[d]thiazol-2-yl)phenylamino]benzoic acid (BPBA), with both Abeta-targeting and inflammasome-inhibiting capabilities was designed and synthesized. BPBA inhibited self- and Cu2+- or Zn2+-induced Abeta aggregation, disaggregated the already formed Abeta aggregates, and reduced the neurotoxicity of Abeta aggregates; it also inhibited the activation of the NLRP3 inflammasome and reduced the release of IL-1beta in vitro and vivo. Moreover, BPBA decreased the production of reactive oxygen species (ROS) and alleviated Abeta-induced paralysis in transgenic C. elegans with the human Abeta42 gene. BPBA exerts an anti-AD effect mainly through dissolving Abeta aggregates and inhibiting NLRP3 inflammasome activation synergistically.
35382471	26	31	Abeta	Gene	351
35382471	48	53	NLRP3	Gene	114548
35382471	91	110	Alzheimer's disease	Disease	MESH:D000544
35382471	112	131	Alzheimer's disease	Disease	MESH:D000544
35382471	133	135	AD	Disease	MESH:D000544
35382471	142	167	neurodegenerative illness	Disease	MESH:D019636
35382471	190	201	memory loss	Disease	MESH:D008569
35382471	203	222	cognitive disorders	Disease	MESH:D003072
35382471	227	254	impaired behavioral ability	Disease	MESH:D001523
35382471	278	283	Abeta	Gene	351
35382471	374	379	NLRP3	Gene	114548
35382471	436	438	AD	Disease	MESH:D000544
35382471	440	445	Abeta	Gene	351
35382471	529	534	NLRP3	Gene	114548
35382471	586	594	IL-1beta	Gene	3553
35382471	606	623	neuroinflammation	Disease	MESH:D000090862
35382471	650	701	2-[2-(benzo[d]thiazol-2-yl)phenylamino]benzoic acid	Chemical	-
35382471	703	707	BPBA	Chemical	-
35382471	720	725	Abeta	Gene	351
35382471	807	811	BPBA	Chemical	-
35382471	832	836	Cu2+	Chemical	-
35382471	841	845	Zn2+	Chemical	-
35382471	854	859	Abeta	Gene	351
35382471	906	911	Abeta	Gene	351
35382471	940	953	neurotoxicity	Disease	MESH:D020258
35382471	957	962	Abeta	Gene	351
35382471	1015	1020	NLRP3	Gene	114548
35382471	1061	1069	IL-1beta	Gene	3553
35382471	1099	1103	BPBA	Chemical	-
35382471	1132	1155	reactive oxygen species	Chemical	MESH:D017382
35382471	1157	1160	ROS	Chemical	MESH:D017382
35382471	1177	1182	Abeta	Gene	351
35382471	1191	1200	paralysis	Disease	MESH:D010243
35382471	1215	1225	C. elegans	Species	328850
35382471	1235	1240	human	Species	9606
35382471	1241	1248	Abeta42	Gene	351
35382471	1255	1259	BPBA	Chemical	-
35382471	1275	1277	AD	Disease	MESH:D000544
35382471	1311	1316	Abeta	Gene	351
35382471	1343	1348	NLRP3	Gene	114548
35382471	Association	114548	3553
35382471	Positive_Correlation	114548	351
35382471	Association	MESH:D000090862	351
35382471	Association	MESH:D000544	114548
35382471	Association	MESH:D000090862	3553
35382471	Association	MESH:D000544	351
35382471	Association	351	3553
35382471	Association	MESH:D020258	351
35382471	Association	MESH:D000090862	114548
35382471	Positive_Correlation	MESH:D010243	351

